Vivos Therapeutics
Price & Volume
Stats
See more52W Range | $1.91-$6.28 |
Market Cap | $16M |
Shares Short | 220,591 |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 13.9% |
Gross Profit (12 Mos) | $9M |
Diluted EPS | -$2.22 |
News
See moreYahoo Finance • last month
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
Yahoo Finance • last month
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
Yahoo Finance • last year
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Yahoo Finance • last year
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
About
CEO | Mr. R. Kirk Huntsman |
CFO | Mr. Bradford K. Amman |
Address | 7921 Southpark Plaza, Littleton, CO, United States, 80120 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 109 |
